UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The chlorophyll catabolite pheophorbide a as a photosensitizer for the photodynamic therapy

Current medicinal chemistry, 2012-02, Vol.19 (6), p.799-807

2012

Volltextzugriff (PDF)

The Combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory Properties in Novel In Vivo and In Vitro Models of Endometriosis

Mediators of Inflammation, 2015-01, Vol.2015 (2015), p.809-817-475

2015

Volltextzugriff (PDF)

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Leukemia, 2015-02, Vol.29 (2), p.406-414

2015

Volltextzugriff (PDF)

Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion

The Journal of pharmacology and experimental therapeutics, 2006-04, Vol.317 (1), p.284-291

2006

Volltextzugriff (PDF)

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A

European journal of cancer (1990), 2002, Vol.38 (3), p.427-435

2002

Volltextzugriff (PDF)

The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure

Journal of biological inorganic chemistry, 2015-07, Vol.20 (5), p.831-840

2015

Volltextzugriff (PDF)

834: Chemotherapeutic-loaded biodegradable nanoparticles in the treatment of chronic lymphocytic leukemia

European journal of cancer (1990), 2014-07, Vol.50, p.S202-S202

2014

Volltextzugriff (PDF)

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

The Lancet infectious diseases, 2018-03, Vol.18 (3), p.318-327

2018

Volltextzugriff (PDF)

A novel retinoic butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results

Leukemia, 2006-05, Vol.20 (5), p.785-792

2006

Volltextzugriff (PDF)

Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells

Anti-cancer drugs, 2000-09, Vol.11 (8), p.665-672

2000

Volltextzugriff (PDF)

5.58 Advances in the Use of Targeted Nanoparticles for the Treatment of B-CLL

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S284-S284

2011

Volltextzugriff (PDF)

Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity

International journal of immunopathology and pharmacology, 2009, Vol.22 (1), p.73-83

2009

Volltextzugriff (PDF)

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

International journal of nanomedicine, 2015-01, Vol.10 (default), p.4099-4109

2015

Volltextzugriff (PDF)

The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation

Journal of reproductive immunology, 2018-08, Vol.128, p.59-60

2018

Volltextzugriff (PDF)

Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen

Clinical cancer research, 2003-05, Vol.9 (5), p.1898-1905

2003

Volltextzugriff (PDF)

Tumour cell uptake G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells

Anticancer research, 2001-05, Vol.21 (3B), p.1893

2001

Volltextzugriff (PDF)

Synthesis and Chemical−Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)

Journal of medicinal chemistry, 2004-02, Vol.47 (5), p.1110-1121

2004

Volltextzugriff (PDF)

Antibiotic research and development: business as usual?

Journal of antimicrobial chemotherapy, 2015, Vol.70 (6), p.1604-1607

2015

Volltextzugriff (PDF)

Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes

The Journal of pharmacology and experimental therapeutics, 2000-12, Vol.295 (3), p.927

2000

Volltextzugriff (PDF)

Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But

Clinical cancer research, 2004-07, Vol.10 (14), p.4822-4830

2004

Volltextzugriff (PDF)

Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.737-744

2004

Volltextzugriff (PDF)

Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates

Farmaco (Società chimica italiana : 1989), 2003-12, Vol.58 (12), p.1307-1312

2003

Volltextzugriff (PDF)

Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity

International journal of oncology, 2002-12, Vol.21 (6), p.1331

2002

Volltextzugriff (PDF)

Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2

International journal of immunopharmacology, 1999-01, Vol.21 (1), p.27-46

1999

Volltextzugriff (PDF)

Recruitment of human endothelial cells expressing alpha-gal epitopes into tumor vessels as a novel strategy to promote complement dependent tumor regression

Molecular immunology, 2010-08, Vol.47 (13), p.2287-2288

2010

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(154)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(170)
Italienisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(96)
Animals
(91)
Mice
(87)
Humans
(48)
Female
(45)
Oncology
(38)
Biological And Medical Sciences
(35)
Pharmacology & Pharmacy
(31)
Medical Sciences
(30)
Mice, Inbred C57bl
(28)
Lung Neoplasms - Secondary
(26)
Lung Neoplasms - Drug Therapy
(25)
Antineoplastic Agents
(20)
Antineoplastic Agents - Therapeutic Use
(20)
Pharmacology. Drug Treatments
(20)
Antineoplastic Agents - Pharmacology
(19)
Lung Neoplasms - Pathology
(17)
Cell Line, Tumor
(16)
Metastasis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The chlorophyll catabolite pheophorbide a as a photosensitizer for the photodynamic therapy

The Combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory Properties in Novel In Vivo and In Vitro Models of Endometriosis

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A

The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure

834: Chemotherapeutic-loaded biodegradable nanoparticles in the treatment of chronic lymphocytic leukemia

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

A novel retinoic butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results

Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells

5.58 Advances in the Use of Targeted Nanoparticles for the Treatment of B-CLL

Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

The complement component C3 is expressed by the endometrial ectopic tissue and is involved in the endometriotic lesion formation

Dual action of NAMI-A in inhibition of solid tumor metastasis: Selective targeting of metastatic cells and binding to collagen

Tumour cell uptake G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells

Synthesis and Chemical−Pharmacological Characterization of the Antimetastatic NAMI-A-Type Ru(III) Complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-Dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)

Antibiotic research and development: business as usual?

Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes

Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But

Intratumoral NAMI-A treatment triggers metastasis reduction, which correlates to CD44 regulation and tumor infiltrating lymphocyte recruitment

Improvement of physicochemical and biopharmaceutical properties of theophylline by poly(ethylene glycol) conjugates

Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity

Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2

Recruitment of human endothelial cells expressing alpha-gal epitopes into tumor vessels as a novel strategy to promote complement dependent tumor regression

Suchergebnisse filtern